Company Filing History:
Years Active: 2025
Title: Christopher S Eickhoff: Innovator in Influenza Research
Introduction
Christopher S Eickhoff is a notable inventor based in St. Louis, MO. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza. His work focuses on generating an effective immune response to combat this prevalent virus.
Latest Patents
Eickhoff holds a patent for "Peptides for inducing heterosubtypic influenza T cell responses." This invention provides compositions and methods for generating an anti-influenza immune response. It identifies conserved T cell epitopes within matrix protein and nucleoprotein components of the influenza virus. The patent further describes methods for vaccinating subjects with formulations of these peptides for the treatment or prevention of influenza infection.
Career Highlights
Throughout his career, Eickhoff has worked with esteemed institutions such as Saint Louis University and Epivax, Inc. His research has been pivotal in advancing the understanding of influenza and developing effective vaccines.
Collaborations
Eickhoff has collaborated with notable colleagues, including Daniel Hoft and Annie De Groot. Their combined expertise has contributed to the success of various research initiatives in the field of immunology.
Conclusion
Christopher S Eickhoff is a distinguished inventor whose work in influenza research has the potential to impact public health significantly. His innovative approaches to vaccine development continue to pave the way for advancements in immunology.